Details of Drug-Drug Interaction
| Drug General Information (ID: DDIUFZ3H4K) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Drug Name | Torasemide | Drug Info | Cefotetan | Drug Info | |||||
| Drug Type | Small molecule | Small molecule | |||||||
| Therapeutic Class | Diuretics | Antibiotics | |||||||
| Structure | |||||||||
| Mechanism of Torasemide-Cefotetan Interaction (Severity Level: Moderate) | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Increased renal excretion (Unspecific) Click to Show/Hide Mechanism Graph | |||||||||
| Drug Name | Torasemide | Cefotetan | |||||||
| Mechanism | Increase the risk of cephalosporins-induced nephrotoxicity | Cephalosporins | |||||||
| Key Mechanism Factor 1 | |||||||||
| Factor Name | Pharmacokinetics | ||||||||
| Factor Description | Alters the excretion of the drug, resulting in changes in the plasma concentration of the drug and affecting the pharmacological effects. | ||||||||
| Mechanism Description |
|
||||||||
| Recommended Action | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Management | Although data are primarily limited to cephaloridine, which is no longer commercially marketed, caution may be advisable in patients receiving a loop diuretic in combination with other cephalosporins. Renal function should be monitored, particularly when high dosages are used or when these medications are administered in the elderly or patients with preexisting renal impairment. | ||||||||
